Early research (Phase 1)Study completedNCT00032825What this trial is testingKetoconazole Plus Docetaxel to Treat Prostate CancerWho this might be right forProstatic Neoplasms National Cancer Institute (NCI) 674
Testing effectiveness (Phase 2)Study completedNCT00006241What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Relapsed Low- or Intermediate-Grade Non-Hodgkin's LymphomaWho this might be right forLymphoma Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Ended earlyNCT01232556What this trial is testingInotuzumab Ozogamicin Plus Rituximab For Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma Patients Who Are Not Candidates For Intensive High-Dose ChemotherapyWho this might be right forLymphoma, Non-Hodgkin Pfizer 338
Not applicableStudy completedNCT01232062What this trial is testingStudy of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer PatientsWho this might be right forBreast NeoplasmsNeoplasm Metastasis Peking University Cancer Hospital & Institute 46
Testing effectiveness (Phase 2)Study completedNCT00004088What this trial is testingCombination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple MyelomaWho this might be right forMultiple Myeloma and Plasma Cell Neoplasm City of Hope Medical Center 77
Large-scale testing (Phase 3)UnknownNCT00463463What this trial is testingZevalin and BEAM High-dose Chemotherapy Compared With BEAM Alone as Conditioning Regimen in Patients With Chemosensitive Relapse of Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's Lymphoma Soroka University Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT07105592What this trial is testingNimotuzumab Plus Adebrelimab With Chemotherapy in Cisplatin-Ineligible Patients With Head And Neck Squamous Cell CarcinomaWho this might be right forHead and Neck Squamous Cell Carcinoma Fudan University 68
Testing effectiveness (Phase 2)Looking for participantsNCT05728268What this trial is testingNeoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation IndexWho this might be right forBreast Cancer Shantou Central Hospital 64
Testing effectiveness (Phase 2)Study completedNCT00008190What this trial is testingCombination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute LeukemiaWho this might be right forLeukemia Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT00647049What this trial is testingFreiburg ZNS-NHL StudyWho this might be right forPrimary Non Hodgkin Lymphoma of the Central Nervous System University Hospital Freiburg 78
Testing effectiveness (Phase 2)Study completedNCT00965289What this trial is testingHigh-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell LymphomaWho this might be right forB-Cell Lymphoma Nantes University Hospital 42
Testing effectiveness (Phase 2)Ended earlyNCT04851834What this trial is testingNTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade GliomaWho this might be right forAdvanced Solid TumorPlatinum-Resistant Ovarian CancerPlatinum-Resistant Urothelial Carcinoma+1 more Xennials Therapeutics Australia Pty Ltd 12
Testing effectiveness (Phase 2)Study completedNCT00794261What this trial is testingStem Cell Mobilization With Pegfilgrastim in Lymphoma and MyelomaWho this might be right forLymphomaMyeloma Centre Leon Berard 150
Early research (Phase 1)Ended earlyNCT04196010What this trial is testingContinuous Infusion Chemotherapy (CI-CLAM) for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Other High-Grade Myeloid NeoplasmsWho this might be right forMyeloid NeoplasmRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia University of Washington 13
Testing effectiveness (Phase 2)Looking for participantsNCT07259707What this trial is testingGilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AMLWho this might be right forAcute Myeloid LeukemiaFLT3 Internal Tandem Duplication PositiveIntermediate Risk Acute Myeloid Leukemia+1 more First Affiliated Hospital of Zhejiang University 25
Early research (Phase 1)Study completedNCT00004174What this trial is testingCombination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast CancerWho this might be right forBreast Cancer Northwestern University 30
Testing effectiveness (Phase 2)Study completedNCT01426295What this trial is testingPharmaco-economic Study of a New Medical Device Performed From the Perspective of the HospitalWho this might be right forHematologic Disease Nantes University Hospital 92
Early research (Phase 1)Study completedNCT02038777What this trial is testingPF-04449913 In Japanese Patients With Select Hematologic MalignanciesWho this might be right forAcute Myeloid Leukemia Pfizer 48
Not applicableStudy completedNCT02860585What this trial is testingEvaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell TransplantationWho this might be right forBreast Neoplasms Institut Paoli-Calmettes 235
Testing effectiveness (Phase 2)Study completedNCT00003811What this trial is testingCombination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell TumorsWho this might be right forChildhood Germ Cell TumorDrug/Agent Toxicity by Tissue/OrganExtragonadal Germ Cell Tumor+1 more Children's Oncology Group 27